Facial Expression Recognition of Emotion and Categorization of Emotional Words in Gilles de la Tourette's Syndrome
NCT ID: NCT00664300
Last Updated: 2011-01-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2007-08-31
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This disease is associated with an dopamine system imbalance which could be responsible of a specific trouble in the recognition in some facial expression. This has been already shown in Gilles de la Tourette patients with obsessive compulsive behaviour.
We hypothesise that patients with Gilles de la Tourette's syndrome present a dysfunction of voluntary and automatic treatment of emotional information.
The main purpose of this study is to show if patients with Gilles de la Tourette's syndrome present a lack of specific facial expression recognition of emotion and determinate more precisely if this alteration involves the cortical way (high frequency way) or the under cortical way (low frequency way).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Frontal Cortex in the Pathophysiology of Gilles de la Tourette Syndrome (GTS)
NCT03604510
Multimodal Electrophysiological Study of Cortico-subcortical Biomarkers of Tics in Tourette Syndrome
NCT06909656
Cognitive and Brain Development in Adolescents With Gilles de la Tourette Syndrome
NCT04179435
Decision-making and Emotion Recognition in Essential Tremor
NCT01223144
Investigations of the Pathophysiology of Gilles de la Tourette Syndrome. Part 1: Simultaneous PET and 3T MRI
NCT05232955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study progress (patients):
Inclusion visit :
Psychiatric evaluation Psychological evaluation
Ophthalmic visit
Protocol :
Facial expression recognition test Lexical decision test
Study progress (healthy volunteers):
Psychiatric evaluation Ophthalmic visit Facial expression recognition test Lexical decision test
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2
One group with Gilles de la Tourette's Syndrome One group with healthy paired volunteers
Facial expression recognition of emotion
Facial expression recognition test Lexical decision test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Facial expression recognition of emotion
Facial expression recognition test Lexical decision test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with a Gilles de la Tourette 's syndrome such as defined in the DSMIV
* Stability of treatment \>1 month
* Mini Mental State \> 26
* Affiliation to social security
* Agreement of patients
Exclusion Criteria
* Patients with serious neurological pathologies
* Patients with a vision contrast altered.
* Patients who do not understand the words associated with an emotion
* Pregnant women
* Person who participate to an other study
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
CHU Clermont-Ferrand
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Isabelle Jalenques, PUPH
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RBHP 2007 Jalenques
Identifier Type: -
Identifier Source: secondary_id
CHU-0032
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.